Rationale: Cardiac remodeling and subsequent heart failure remain critical issues after myocardial infarction despite improved treatment and reperfusion strategies. Recently, cardiac regeneration has been demonstrated in fish and newborn mice following apex resection or cardiac infarctions. Two key issues remain to translate findings in model organisms to future therapies in humans: what is the mechanism and can cardiac regeneration indeed occur in newborn humans?
INTRODUCTION
Despite significant improvements in prevention and therapies, the burden of myocardial infarction (MI) remains high. 1 Recent advances in the treatment of the disease have resulted in marked improvement in the initial survival of patients. However, many patients develop heart failure because the initial loss of cardiomyocytes cannot be compensated, resulting in tissue remodeling and functional deterioration of the heart. 2 Although there have been great advances in the understanding of heart failure in recent decades 3 and acute treatment of heart attacks has markedly improved survival, one key issue for human health is how to effectively regenerate the heart after injury.
Major efforts are underway to develop strategies for myocardial recovery and thus improve cardiac morbidity and mortality, including (stem) cell based therapies, 4 ,5 transdifferentiation of noncardiomyocytes into cardiomyocytes, 6, 7 or to stimulate the intrinsic regenerative potential. [8] [9] [10] [11] However, the fact remains that lost myocardium can still not be effectively regenerated in human patients. 12, 13 Pioneering experiments demonstrated that fish can completely regenerate the heart following resection of the heart apex, 14 spurning a plethora of studies using fish as a model organism. 15, 16 Whereas axolotls 17 and zebrafish 14 have the potential of lifelong myocardial recovery, it has been recently shown that newborn mice, but not mice beyond one week of age, can regenerate the cardiac apex following resection. 18 However, this apex resection model has been recently questioned. 19 Moreover our group and Olson's group have recently reported complete morphologic and functional cardiac repair in newborn mice following severe myocardial infarction. 20, 21 Besides the elucidation of the underlying mechanism for neonatal cardiac repair, 22 one key question remains: "Can we translate these models to the human heart considering fundamental differences in basic cardiac physiology?" Here, we report the case of severe myocardial infarction in a newborn child and provide evidence of complete functional cardiac recovery in human.
METHODS
Clinical assays were performed following standard protocols and are described in the online supplement.
RESULTS
A 27 years old woman gave vaginal birth to a boy at the end of the 39 th gestation week. No complications were observed throughout the pregnancy and no morphological or functional irregularities were evident in the developing fetus as determined by transabdominal ultrasound and cardiotocography. The labor was uneventful, further supported by the normal values of the umbilical cord arterial blood. However, the newborn manifested severe cyanosis and oxygen saturation was markedly decreased. Despite ventilation therapy, no improvement of the child's health was achieved leading to examination of the heart and immediate referral to our pediatric center (Online figure IA).
Initial examination using electrocardiography (ECG) revealed signs of acute myocardial ischemia ( Figure 1A ). Echocardiography showed severely impaired left ventricular function with abnormal regional wall contractions ( Figure 1B) . The cardiac biomarker proteins troponin T and creatine kinase, both clinical markers of myocardial damage, 23 were massively increased within hours after birth ( Figure 1C+D ). Moreover, we detected increased levels of NTproBNP (Online figure IB) , a well-established marker of elevated intracardiac pressure. 24 Of note, troponin T is released from dying cardiomyocytes and directly correlates with the extent of cardiomyocyte necrosis. 25 In our patient we found troponin T serum levels close to 15000ng/L ( Figure 1C ), levels that are even higher than in very severe cases of myocardial infarctions in the adult. Thus, all these parameters show that the newborn child had suffered severe cardiac injury.
To determine the cause of myocardial damage, we performed Doppler echocardiography. We observed a block in blood flow in the left anterior descending artery (LAD) (Figure 2A ), indicative of occlusion of this key coronary blood vessel. To directly demonstrate LAD obstruction, we performed cardiac angiography. We indeed observed a complete thrombotic occlusion of the proximal LAD without any detectable collateral blood flow ( Figure 2B ). No obvious cause for thrombus formation could be identified, e.g. there was no enhanced coagulation and illicit drug abuse of the mother was excluded. The child developed acute left ventricular heart failure necessitating inotropic therapy and the implantation of an extracorporeal membrane oxygenation (ECMO) device (Online figure IA). Intravenous thrombolysis was initiated ~ 28 hours after the first symptoms. Importantly, Doppler echocardiography as well as repeated angiography showed reopening of the occluded LAD lesion ( Figure 2A+B ). Despite reestablishment of coronary blood flow, the child continued to present with myocardial damage as evidenced by anteroseptal edema and regional hypokinesis at the area of infarction ( Figure 3A+B online videos I and II). Moreover, following thrombolysis, we detected pathological ECG Q-waves ( Figure 3C ), further supporting myocardial damage. Thus, the newborn suffered from LAD occlusion for more than 20 hours resulting in massive myocardial infarction.
The following sub-acute phase was characterized by continuous cardiac improvement without any complications. All serum markers for cardiac damage, i.e. troponin T and creatine kinase, rapidly returned to normal levels ( Figure 4A ). Moreover, NTproBNP serum level returned to background levels ( Figure 4B ). In line with normalized NTproBNP levels, cardiac function, i.e. fractional shortening and ejection fractions, markedly improved to levels observed in age-matched, healthy normal children ( Figure 4C+D ). The child was discharged one and a half months after birth with apparently normal heart parameters. The patient was followed up on a regular basis for up to one year; and the boy's development was indistinguishable to agematched healthy babies (Online figure IIA) . Neither morphological nor neurological deficits were found up to his first birthday. Most importantly at one year of age, echocardiography and NTproBNP evaluations showed normal cardiac morphologies and heart function ( Figure 4B+C , and Online figure IIA and IIB). Thus, based on all available evidence this child had no apparent signs of any structural heart abnormalities and completely recovered cardiac function.
DISCUSSION
We present the case of a newborn patient with severe anteroseptal ST elevation myocardial infarction, confirmed by multiple assays such as angiography, ECG, echocardiography, and increased cardiac serum biomarkers. Amazingly, the patient's heart rapidly recovered despite very late thrombolytic reperfusion therapy and was indistinguishable in function and morphology to hearts of comparable 1-yearold infants. Of note, a few case reports have been published describing patients suffering from myocardial infarction in the neonatal period without structural heart disease [26] [27] [28] [29] [30] [31] [32] . All reported newborns with documented myocardial infarction that survived the acute phase apparently recovered their heart function. [26] [27] [28] 31, 32 Since reperfusion therapy was successfully performed in our patient we cannot exclude the phenomena of stunning or hibernation contributing to the profound cardiac improvements in our patient. 33 However, delayed thrombolysis, massive release of cardiomyocyte-specific troponin T, indicative of cardiomyocyte necrosis, and ECG-and echocardiography-documented myocardial damage all clearly indicate that the newborn child had suffered from severe myocardial infarction with subsequent severe structural and functional cardiac impairments. Importantly, the cardiac injury was completely repaired as defined by normal cardiac functional and structural parameters. Since the now nearly 3 years old boy is healthy, we were not allowed by the ethics board to perform GdMRI under general anesthesia, which however should be performed in the future to assay for possible remaining scar tissue.
Efficient heart regeneration is one of the prime visions for cardiology. Our report reveals that complete functional recovery of a massive myocardial infarction is possible in the newborn human. Thus, fundamental insights gained from cardiac regeneration in fish and neonatal mice might be indeed translatable to future cardiac repair in humans. Whether in humans functional cardiac recovery can also occur following permanent coronary vessel occlusion, as in the rodent MI models, or such recovery relies on reperfusion remains unresolved. Since cardiac repair in neonatal mice is limited to the first week after birth, we would like to urge the pediatric cardiologists to collect further cases of human infants to map the time window for cardiac functional recovery. In addition, it will be important to confirm our findings using imaging (e.g. MRI) of the damaged myocardium. Importantly, our report suggests that humans might have the intrinsic capacity to regenerate their hearts as was shown experimentally for other neonatal mammals. Due to the nature of our human case report we cannot exclude hibernation or stunning and cannot directly prove cellular cardiac regeneration. However, comparable adult human MIs following a proximal LAD occlusion for more than 24 hours with concurrent increases in cardiac enzymes would, based on clinical experience, not result in functional cardiac recovery. Our case report provides a crucial proof of concept on functional cardiac recovery in newborn humans that merits further basic and translational research to possibly one day be able to regenerate a diseased adult human heart.
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Novelty and Significance

What Is Known?
 Adult mammalian hearts do not significantly regenerate irreversible damaged myocardium e.g. following myocardial infarction.
 Cardiac regeneration has been demonstrated in neonatal rodents following experimental apex resection and left anterior descending artery ligation.
What New Information Does This Article Contribute?
 Here, we report a rare human case of functional cardiac recovery following neonatal myocardial infarction. In the light of the recently established concept of mammalian neonatal cardiac regeneration in rodents, these data suggest potential similarities in the human heart.
Major efforts are underway to develop strategies for myocardial recovery. Complete cardiac regeneration has been demonstrated in fish and newborn mice following apex resection or cardiac infarctions. However, adult mammalian hearts do not significantly regenerate irreversible damaged myocardium. One key question is: Can one translate these experimental regeneration models in fish or neonatal mouse to humans considering fundamental differences in basic cardiac physiology? Here we report the case of severe myocardial infarction and cardiac damage in a newborn child on the first day of life. Remarkably, within weeks after the initial ischemic insult, we observed complete cardiac recovery, which translated into longterm normal heart functions. These data show that humans have the intrinsic capability to functionally repair myocardial damage. Whether the observed improvement is due to bona fide regeneration or reversible functional impairment remains unsolved.
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